Apollo endosurgery to be acquired by boston scientific

Boston scientific to acquire apollo for $10.00 per share in cash austin, tx / accesswire / november 29, 2022 / apollo endosurgery, inc. ("apollo") (nasdaq:apen), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, announced today it has entered into a definitive merger agreement to be acquired by boston scientific corporation ("boston scientific"), a global medical technology leader, in an all-cash transaction with an enterprise value of approximately $615 million.[1] this transaction has been unanimously approved by the apollo board of directors.
BSX Ratings Summary
BSX Quant Ranking